News

Speaker at an international workshop at Brussels 8th of december

2017-12-05T09:10:58+01:00December 5th, 2017|

I would like to inform you about a workshop in Brussels about botanicals, health claims, food supplements and Novel Food: 6th Supplement Claims workshop by Health Claims Europe, focusing on the role EU Nutrition and Health Claims could play for botanical extracts, supplements and herbal medicines. More information can be found by the following links: […]

European decision: classification of a FSMP from Denmark

2024-09-10T07:56:31+02:00November 14th, 2016|

At the request of Denmark, the Committee held an exchange of views on the classification of a product as food for special medical purposes (FSMP). The product in question is a tablet for the dietary management of lack of alphalipoic acid in diabetic neuropathy. Member States noted that similar products are placed on the market […]

EU 2016/128 for FSMPs published

2016-02-05T09:31:37+01:00February 5th, 2016|

2 th February 2016, Commission Delegated Regulation (EU) 2016/128 supplementing Regulation (EU) No 609/2013 of the European Parliament and of the Council as regards the specific compositional and information requirements for food for special medical purposes was published, will be enforced > 22th of february 2019.

Important points are

  • national notification, still open which documents have to […]

Technical guidance: Dossiers for FSMPs

2015-07-21T13:52:25+02:00July 21st, 2015|

EFSA has launched (17th of july 2015) an open consultation on its draft scientific and technical guidance for the assessment of products notified as food for special medical purposes in the context of Article 3 of Regulation (EU) No 609/2013. The guidance is for assisting in the preparation and presentation of well-structured dossiers for food […]

Publication of regulation (EU) 1135/2014 “folate for women wishing pregnancy” (28.10.2014)

2015-06-24T15:32:51+02:00October 28th, 2014|

Up to now it is allowed to use the following health claim for food supplements:
“Supplemental folic acid intake increases maternal folate status. Low maternal folate status is a risk factor in the development of neural tube defects in the developing foetus.”
The claim may be used only for food supplements which provide at least 400 μg […]

4 Health Claims rejected

2024-09-10T07:56:32+02:00July 22nd, 2014|

Middle of july 2014, EFSA rejected four health claims (art. 13.5). They concluded that a cause and effect relationship has not been established between the consumption of a combination of lutein and zeaxanthin and improved vision under bright light conditions, regarding a special amino-acid combination, between the consumption of Bimuno® GOS and reducing gastro-intestinal discomfort […]

Go to Top